Juvenile myoclonic epilepsy (JME) is a type of epilepsy that starts in childhood or the teen years. People who have it wake up from sleep with quick, jerking movements of their arms and legs. These ...

Scientists have found a way to rapidly suppress epilepsy in mouse models by manipulating a known genetic pathway using a cancer drug currently in human clinical trials for the treatment of brain and ...

Medical scientists have developed an advanced method for perfectly detecting low-level somatic mutation in patients with intractable epilepsy. Their study showed that deep sequencing replicates of ...

Surgeons who observe persistent fluid buildup after disconnecting epileptic and healthy brain areas should think twice before installing low-pressure nonprogrammable drainage shunts, according to a ...

Gaucher disease, the inherited deficiency of lysosomal glucocerebrosidase, presents with a wide spectrum of manifestations. Although Gaucher disease has been divided into three clinical types, ...

Levetiracetam reduces tonic-clonic seizures by over 77% in clinical studies. Ethosuximide is highly effective for absence seizures, especially in children. Valproate remains the gold standard for ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

What is Juvenile Myoclonic Epilepsy? Juvenile myoclonic epilepsy (JME) is an epileptic condition that develops in children and adolescents, invariably between the ages of 8 and 26 with most of the ...